Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study for Patients With Dravet Syndrome Who Previously Participated in Studies of STK-001

NCT04740476 is registered in ClinicalTrials.gov with Stoke Therapeutics, Inc as lead sponsor.

NCT NCT04740476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study for Patients With Dravet Syndrome Who Previously Participated in Studies of STK-001
Lead sponsor
Stoke Therapeutics, Inc
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 20, 2021
Completion date
March 31, 2029
Enrollment
60 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome